Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Shun Hayashi, Hiroko Kawaguchi, Takao Watanabe, Izuru Miyawaki, Tatsuki Fukami & Miki Nakajima. (2023) Estimation of contribution of CYP2D6 to tipepidine metabolism in humans and prolongation of the half-life of tipepidine by combination use with a CYP2D6 inhibitor in chimeric mice with humanised liver. Xenobiotica 53:4, pages 241-247.
Read now
Read now
Ann C. Childress, Nathalie Beltran, Carl Supnet & Margaret D. Weiss. (2021) Reviewing the role of emerging therapies in the ADHD armamentarium. Expert Opinion on Emerging Drugs 26:1, pages 1-16.
Read now
Read now
Marco Pozzi, Silvana Bertella, Erika Gatti, Gabriëlla G. A. M. Peeters, Carla Carnovale, Stefania Zambrano & Maria Nobile. (2020) Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD). Expert Opinion on Emerging Drugs 25:4, pages 395-407.
Read now
Read now
Ann Childress & Chau Tran. (2016) Current Investigational Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder. Expert Opinion on Investigational Drugs 25:4, pages 463-474.
Read now
Read now
Tsuyoshi Sasaki, Kenji Hashimoto, Masumi Tachibana, Tsutomu Kurata, Hiroshi Kimura, Hideki Komatsu, Masatomo Ishikawa, Tadashi Hasegawa, Akihiro Shiina, Tasuku Hashimoto, Nobuhisa Kanahara, Tetsuya Shiraishi & Masaomi Iyo. (2014) Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study. Neuropsychiatric Disease and Treatment 10, pages 719-722.
Read now
Read now
Articles from other publishers (17)
Haichang Luo, Ezequiel Marron Fernandez de Velasco & Kevin Wickman. (2022)
Neuronal G protein-gated K
+
channels
. American Journal of Physiology-Cell Physiology 323:2, pages C439-C460.
Crossref
Crossref
Konstantin Mechler, Tobias Banaschewski, Sarah Hohmann & Alexander Häge. (2022) Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacology & Therapeutics 230, pages 107940.
Crossref
Crossref
Wei Zhao, Yane Yin, Fuxiang Qin, Xinyu Lin & Liming Zhang. (2021) Effects of early intake of amino acid on the neurodevelopmental outcomes in very low birth weight infants at correct age of 20 months and school age. Irish Journal of Medical Science (1971 -) 191:1, pages 283-288.
Crossref
Crossref
Pozzi Marco, Mauri Maddalena, Bertella Silvana, Gatti Erika & Nobile Maria. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
256
285
.
Yulin Zhao, Isabel Gameiro-Ros, Ian W. Glaaser & Paul A. Slesinger. (2021) Advances in Targeting GIRK Channels in Disease. Trends in Pharmacological Sciences 42:3, pages 203-215.
Crossref
Crossref
Takuya Saito, Yushiro Yamashita, Akemi Tomoda, Takashi Okada, Hideo Umeuchi, Saki Iwamori, Satoru Shinoda, Akiko Mizuno-Yasuhira, Hidetoshi Urano, Izumi Nishino & Kazuhiko Saito. (2020) Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder. BMC Psychiatry 20:1.
Crossref
Crossref
Chihiro Takase, Kentaro Shirai, Yu Matsumura, Tomohiro Watanabe, Akimitsu Watanabe, Ayaka Hirasawa-Inoue, Takeshi Mizuguchi, Naomichi Matsumoto, Kenji Sugai & Masaharu Hayashi. (2020) KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report. Brain and Development 42:8, pages 607-611.
Crossref
Crossref
Georg C. Ziegler, Christoph Röser, Tobias Renner, Tim Hahn, Ann‐Christine Ehlis, Heike Weber, Astrid Dempfle, Susanne Walitza, Christian Jacob, Marcel Romanos, Andreas J. Fallgatter, Andreas Reif & Klaus‐Peter Lesch. (2019)
KCNJ6
variants modulate reward‐related brain processes and impact executive functions in attention‐deficit/hyperactivity disorder
. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 183:5, pages 247-257.
Crossref
Crossref
Sara Dehbozorghi, Sayna Bagheri, Kamyar Moradi, Kamyar Shokraee, Mohammad‐Reza Mohammadi & Shahin Akhondzadeh. (2019) Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial. Psychiatry and Clinical Neurosciences 73:11, pages 690-696.
Crossref
Crossref
Risa Miki, Ikutaro Honda, Ryota Hamasaki, Ryo Kawahara, Fumio Soeda, Tetsuya Shirasaki, Shogo Misumi & Kazuo Takahama. (2019) Effects of tipepidine on MK-801-induced cognitive impairment in mice. Brain Research 1710, pages 230-236.
Crossref
Crossref
Wayland E. Noland, Matthew P. Huisenga, Ryan J. Herzig, John A. Rosenow, Hoyeon Kim, Neil J. Kroll, Andrei Nesmelov, Benjamin T. Johnson, Nathan S. Duncan, Jidapa Ratanayanon, Ruixian A. Yue, Kenny Xiong, Bee K. Ong, Diane T. Vo, Nathan D. Klein, Simon B. Lang, Jacob K. Riley, Steven P. Daniels & Kenneth J. Tritch. (2018)
A Diels–Alder/Ene Cascade Leading to 5‐(Pyrrolidin‐3‐yl)thieno[3,2‐
e
]isoindoles from Ketone‐derived 2‐Vinylthiophenes and
N
‐Phenylmaleimide
. Journal of Heterocyclic Chemistry 55:12, pages 2698-2714.
Crossref
Crossref
Ruben Vardanyan. 2017. Piperidine-Based Drug Discovery. Piperidine-Based Drug Discovery
127
146
.
Michael A. Mooney, Shannon K. McWeeney, Stephen V. Faraone, Anke Hinney, Johannes Hebebrand, Joel T. Nigg & Beth Wilmot. (2016) Pathway analysis in attention deficit hyperactivity disorder: An ensemble approach. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 171:6, pages 815-826.
Crossref
Crossref
Fumio Soeda, Yoshiko Fujieda, Mizue Kinoshita, Tetsuya Shirasaki & Kazuo Takahama. (2016) Centrally acting non-narcotic antitussives prevent hyperactivity in mice: Involvement of GIRK channels. Pharmacology Biochemistry and Behavior 144, pages 26-32.
Crossref
Crossref
Kenji Hashimoto & Tsuyoshi Sasaki. (2014) Old drug tipepidine as new hope for children with ADHD. Australian & New Zealand Journal of Psychiatry 49:2, pages 181-182.
Crossref
Crossref
Jody Mayfield, Yuri A. Blednov & R. Adron Harris. 2015. Structure to Function of G Protein-Gated Inwardly Rectifying (GIRK) Channels. Structure to Function of G Protein-Gated Inwardly Rectifying (GIRK) Channels
279
313
.
Ian W. Glaaser & Paul A. Slesinger. 2015. Structure to Function of G Protein-Gated Inwardly Rectifying (GIRK) Channels. Structure to Function of G Protein-Gated Inwardly Rectifying (GIRK) Channels
117
160
.